Indian Pharma industry moving towards formulations

Indian Pharma industry is slowing moving up the value chain. Earlier it used to manufacture active pharmaceutical ingredient at low cost compared to world. Now with competition from China, which provides API at 15-20% low cost, it makes sense to shift focus elsewhere. Many top companies like Lupin, Novartis, Ranbaxy have less revenue stream from API than from formulations. There could also be the reason that formulation business has grown faster than APIs for some companies. API is low scale commodity with low margin. Moreover, with a large number of patent expiries in developed markets like the US and Europe, Indian companies, with skills to develop and manufacture low-cost generic drugs, see a much more lucrative opportunity there than utilising their capacities for manufacturing APIs.
Read More

  • No Image
    Vesper Group

    Vesper Group was established by Dr. Suresh Sharma. The company is engaged in production of drugs in Animal Health Care and Biotechnology Sector

  • No Image
    Vikram Thermo India Ltd

    Vikram Thermo India Ltd., was born in 1984 at Chhatral, near Ahmedabad first time in India with its first plant for manufacturing Diphenyl Oxide with the name of Vikram Enterpri

  • No Image
    Virbac Animal Health India Pvt Ltd

    Virbac Animal Health India Pvt Ltd is an independent pharmaceutical company exclusively dedicated to animal health based out of France. The group is spread across over 100 count

  • No Image
    Virchow Laboratories Pvt Ltd

    Virchow Group comprises of six active pharmaceutical ingredient (API) and drug intermediate manufacturing units and two biotech units. Incorporated in 1981, the flagship company